What is Deepsight Technology?
Founded in 2019 and headquartered in San Francisco, Deepsight Technology operates at the intersection of artificial intelligence and medical diagnostics. The company specializes in the development of sophisticated computer vision sensing technology designed to enhance the accuracy and efficiency of medical imaging. By integrating deep learning algorithms with advanced hardware, Deepsight aims to provide clinicians with actionable insights that were previously obscured by traditional imaging limitations. Their market position is defined by a commitment to transforming the standard of care through technological innovation, effectively bridging the gap between raw diagnostic data and clinical decision-making.
How much funding has Deepsight Technology raised?
Deepsight Technology has raised a total of $25M across 1 funding round:
Series A
$25M
Series A (2021): $25M with participation from Time BioVentures, Wing Venture Capital, Alter Venture Partners, and Deerfield
Key Investors in Deepsight Technology
Time BioVentures
Time BioVentures is a full-spectrum healthcare and life sciences venture capital firm that finances innovative entrepreneurs developing transformative technologies to enhance patient quality of life.
Wing Venture Capital
Wing Venture Capital is an early-stage investor and long-term company builder that focuses on equipping founders with resources to develop innovative products in AI and data-driven sectors.
Alter Venture Partners
Alter Venture Partners is a venture capital fund that focuses on disruptive enterprise companies, guiding US-based startups through international expansion and scaling.
What's next for Deepsight Technology?
With the recent capital deployment, Deepsight Technology is expected to prioritize the commercialization of its core sensing platform and the expansion of its clinical validation studies. The strategic roadmap likely includes scaling operations to meet the demands of global healthcare providers and deepening its intellectual property portfolio in the computer vision space. As the company moves into its next phase of growth, the focus will shift toward regulatory milestones and the integration of its technology into existing hospital workflows. By leveraging the expertise of its venture partners, Deepsight is poised to become a critical infrastructure provider in the evolving digital health ecosystem, potentially setting new benchmarks for diagnostic precision and operational efficiency in medical facilities worldwide.
See full Deepsight Technology company page
